| Autor: |
Chandra Sekhar K; Department of Chemistry, Sri Venkateswara University, Tirupati, India., Venkataramaiah C; Department of Zoology, Faculty of Humanities and Sciences, Sri Venkateswara Vedic University, Tirupati, India., Raju CN; Department of Chemistry, Sri Venkateswara University, Tirupati, India. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of receptor and signal transduction research [J Recept Signal Transduct Res] 2020 Oct; Vol. 40 (5), pp. 426-435. Date of Electronic Publication: 2020 Apr 05. |
| DOI: |
10.1080/10799893.2020.1747492 |
| Abstrakt: |
Outstanding increase of oral absorption, bioavailability, and antiviral efficacy of phosphorylated nucleosides and basic antiviral influence of abacavir is the central idea for the development of new series of phosphorylated abacavir (ABC) derivatives. The designed compounds were primarily screened for antiviral nature against HN protein of NDV and VP7 protein of BTV using the molecular environment approach. Out of all the designed compounds, the compounds which are having higher binding energies against these two viral strains were prompted for the synthesis of the target compounds (5A-K). Among the synthesized title compounds (5A-K), the compounds which have exhibited higher dock scores akin to the rest of the compounds were then selected and screened for the antiviral activity against NDV and BTV infected embryonated eggs and BHK 21 cell lines through the in ovo and in vitro approaches. The results revealed that all the designed compounds have formed higher binding energies against both the targets. Among all, the compounds which are selected based on their dock scores such as 5A, 5F, 5G, 5H, 5I, and 5K against NDV and 5J, 5E, 5I, 5C, 5A, and 5K against BTV have shown significant antiviral activity against HN protein of NDV, VP7 protein of Bluetongue virus in both NDV- and BTV-treated embryonated eggs and BHK 21 cell lines. Hence, it is concluded that, the best lead compounds will stand as the potential antiviral agents and prompted them as virtuous therapeutics against NDV and BTV in future. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
